The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial
Open accessAbstract
Aims: We aimed to determine whether treatment with sildenafil improves outcomes of patients with persistent pulmonary hypertension (PH) after correction of valvular heart disease (VHD). Methods and results: The sildenafil for improving outcomes after valvular correction (SIOVAC) study was a multricentric, randomized, parallel, and placebo-controlled trial that enrolled stable adults with mean pulmonary artery pressure ≥ 30 mmHg who had undergone a successful valve replacement or repair procedure at least 1 year before inclusion. We assigned 200 patients to receive sildenafil (40 mg three times daily, n = 104) or placebo (n = 96) for 6 months. The primary endpoint was the composite clinical score combining death, hospital admission for heart failure (HF), change in functional class, and patient global self-assessment. Only 27 patients receiving sildenafil improved their composite clinical score, as compared with 44 patients receiving placebo; in contrast 33 patients in the sildenafil group worsened their composite score, as compared with 14 in the placebo group [odds ratio 0.39; 95% confidence interval (CI) 0.22-0.67; P < 0.001]. The Kaplan-Meier estimates for survival without admission due to HF were 0.76 and 0.86 in the sildenafil and placebo groups, respectively (hazard ratio 2.0, 95% CI = 1.0-4.0; log-rank P = 0.044). Changes in 6-min walk test distance, natriuretic peptides, and Doppler-derived systolic pulmonary pressure were similar in both groups. Conclusion: Treatment with sildenafil in patients with persistent PH after successfully corrected VHD is associated to worse clinical outcomes than placebo. Off-label usage of sildenafil for treating this source of left heart disease PH should be avoided. The trial is registered with ClinicalTrials.gov, number NCT00862043.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908355 · Cited by 2,083
Cited by
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
Self-citation2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00879-2022 · Cited by 2,247
Self-citationPulmonary hypertension due to left heart disease
Vachiéry, J.-L., Tedford, R. J., Rosenkranz, S., Palazzini, M., Lang, I., Guazzi, M., Coghlan, G., Chazova, I., & De Marco, T. (2019) · European Respiratory Journal · doi:10.1183/13993003.01897-2018 · Cited by 555
Houston, B. A., Brittain, E. L., & Tedford, R. J. (2023) · New England Journal of Medicine · doi:10.1056/nejmra2207410 · Cited by 280
The Potential Role of Sildenafil in CancerManagement Through EPR Augmentation
Haider, M., Elsherbeny, A., Pittalà, V., Fallica, A. N., Alghamdi, M. A., & Greish, K. (2021) · doi:10.20944/preprints202104.0679.v1 · Cited by 42
Metadata
- Authors
- Bermejo, J., Yotti, R., García-Orta, R., Sánchez-Fernández, P. L., Castaño, M., Segovia-Cubero, J., Escribano-Subías, P., San Román, J. A., Borrás, X., Alonso-Gómez, A., Botas, J., Crespo-Leiro, M. G., Velasco, S., Bayés-Genís, A., López, A., Muñoz-Aguilera, R., de Teresa, E., González-Juanatey, J. R., Evangelista, A., Mombiela, T., González-Mansilla, A., Elízaga, J., Martín-Moreiras, J., González-Santos, J. M., Moreno-Escobar, E., Fernández-Avilés, F., Sildenafil for Improving Outcomes after VAlvular Correction (SIOVAC) investigators, Bermejo, J., Yotti, R., Mombiela, T., Gónzález-Mansilla, A., Elízaga, J., García-Robles, J. A., Pérez-David, E., Pérez del Villar, C., Sanz, R., Gutierrez-Ibanes, E., Vázquez, M. E., Mur, A., Benito, Y., Martínez-Legazpi, P., Barrio, A., Vázquez, A., García-Orta, R., Uribe, I., González, M., Luis Sánchez, P., González-Santos, J. M., Martín-Moreiras, J., Arribas, A., Clemente Lorenzo, M. M., Diego Nieto, A., Castaño, M., Pérez de Prado, A., Alonso, D., Segovia-Cubero, J., Gómez-Bueno, M., Sayago Silva, I., Ángel Cavero, M., Escribano-Subias, P., Domínguez, L., Tello de Meneses, R., Ruiz Cano, M. J., Jiménez López-Guarch, C., San Román, J. A., Mota, P., Borrás, X., Amorós Galitó, C., Alonso-Gómez, A., Belló Mora, M. C., Mesa Rubio, D., Botas, J., Campuzano, R., Crespo-Leiro, M. G., Marzoa, R., Cuenca, J., Velasco, S., Muñoz, R., Suberviola, V., Beltrán Herrera, C., Mora, L., Mar Sarrión, M., Vaqueriza, D., Bayes-Genís, A., Ferrer, E., González-Juanatey, J. R., Cid, B., Monzonís, A. M., López, A., Arizón de Prado, J. M., Santisteban, M., Mesa Rubio, D., Evangelista, A., García-Dorado, D., de Teresa, E., Jiménez-Navarro, M., Carrasco Chinchilla, F., Moreno-Escobar, E., & Alonso, J.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-12-21
- Volume
- 39
- Issue
- 15
- Pages
- 1255-1264
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2806263607
- Cited by
- 230
- References
- 2
- FWCI
- 16.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial. https://app.cochat.ai/papers/10.1093/eurheartj/ehx700
- The paper
- Bermejo, J., Yotti, R., García-Orta, R., Sánchez-Fernández, P. L., Castaño, M., Segovia-Cubero, J., Escribano-Subías, P., San Román, J. A., Borrás, X., Alonso-Gómez, A., Botas, J., Crespo-Leiro, M. G., Velasco, S., Bayés-Genís, A., López, A., Muñoz-Aguilera, R., de Teresa, E., González-Juanatey, J. R., Evangelista, A., . . . Alonso, J. (2018). Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial. European Heart Journal. https://doi.org/10.1093/eurheartj/ehx700
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.